FrancophonIA/DGT-Translation_Memory huggingface dataset:
English: D.J.
Dutch: Kirkland, (Ed.)
Danish: Kirkland, Cambridge University Press, pp.
Finnish: (1989), Statistical Analysis of In Vivo Cytogenetic Assays, in: D.J.
Greek: D.). Kirkland, Cambridge University Press, pp.
Estonian: Kirkland, Cambridge University Press, pp.
English: The measurement of micronucleated immature (polychromatic) erythrocytes in peripheral blood is equally acceptable in any species in which the inability of the spleen to remove micronucleated erythrocytes has been demonstrated, or which has shown an adequate sensitivity to detect agents that cause structural or numerical chromosome aberrations. Micronuclei can be distinguished by a number of criteria.
Italian: Il conteggio degli eritrociti immaturi (policromatici) contenenti micronuclei nel sangue periferico è ugualmente accettabile nelle specie in cui è stata provata l'incapacità della milza di svolgere la funzione emocatecretica sugli eritrociti contenenti micronuclei o che sia risultata particolarmente sensibile per l'individuazione di agenti che provocano aberrazioni cromosomiche strutturali o numeriche.
Danish: Måling af umodne (polykromatiske) erythrocytter med mikrokeme i det perifere blod kan også accepteres i andre arter, hvor det er vist, at milten ikke kan fjerne erythrocytter med mikrokerner, eller at deres følsomhed over for stoffer, der forårsager strukturelle eller antalsmæssige kromosomaberrationer, er tilstrækkelig.
English: Samples of bone marrow are taken at least twice, starting not earlier than 24 hours after treatment, but not extending beyond 48 hours after treatment with appropriate intervals between samples. The use of sampling times earlier than 24 hours after treatment should be justified.
Danish: Benyttes der to eller flere daglige behandlinger (f.eks. to eller flere behandlinger med 24 timers mellemrum) udtages der for knoglemarvs vedkommende prøver én gang mellem 18 og 24 timer efter den sidste behandling, og for perifert blods vedkommende én gang mellem 36 og 48 timer efter den sidste behandling (12).
English: Samples of peripheral blood are taken at least twice, starting not earlier than 36 hours after treatment, with appropriate intervals following the first sample, but not extending beyond 72 hours. When a positive response is recognised at one sampling time, additional sampling is not required. (b) if two or more daily treatments are used (e.g. two or more treatments at 24 hour intervals), samples should be collected once between 18 and 24 hours following the final treatment for the bone marrow and once between 36 and 48 hours following the final treatment for the peripheral blood (12); Other sampling times may be used in addition, when relevant.
Danish: Derudover kan der udtages prøver på andre tidspunkter, hvis det er relevant.
English: If a test at one dose level of at least 2000 mg/kg body weight using a single treatment, or as two treatments on the same day, produces no observable toxic effects, and if genotoxicity would not be expected based upon data from structurally related substances, then a full study using three dose levels may not be considered necessary. For studies of a longer duration, the limit dose is 2000 mg/kg/body weight/day for treatment up to 14 days, and 1000 mg/kg/body weight/day for treatment longer than 14 days.
Danish: Hvis der ved en test med én dosis på mindst 2000 mg p. kg legemsvægt indgivet på én gang eller i to omgange samme dag ikke kan iagttages nogen toksiske virkninger, og hvis man på grundlag af data om strukturnæssigt beslægtede stoffer ikke forventer gentoksicitet, kan en fuldstændig undersøgelse med tre dosisniveauer anses for unødvendig, for længerevarende undersøgelser er grænsedosis på 2000 mg pr. kg legemsvægt pr. dag for behandlinger over højst 14 dage og på 1000 mg pr. kg legemsvægt pr. dag for behandlinger over mere end 14 dage.
English: Positive results in the micronucleus test indicate that the substance induces micronuclei which are the result of chromosomal damage or damage to the mitotic apparatus in the erythroblasts of the test species. Negative results indicate that, under the test conditions, the test substance does not produce micronuclei in the immature erythrocytes of the test species.
Danish: Et positivt resultat af mikrokernetesten viser, at teststoffet fremkalder mikrokerner, som følge af beskadigelse af kromosomer eller mitoseapparat hos erythroblaster i den undersøgte art. Et negativt resultat viser, at teststoffet under testbetingelserne ikke fremkalder mikrokerner hos umodne erythrocytter i den undersøgte art.
Slovak: Pozitívne výsledky testu mikrojadier naznačujú, že určitá látka vyvoláva mikrojadrá, ktoré sú výsledkom chromozómového poškodenia alebo poškodenia mitotického aparátu v erytroblastoch testovaného druhu.
English: A.W.
Danish: (1983), Micronuclei in Circulating Erythrocytes: A Rapid Screen for Chromosomal Damage During Routine Toxicity Testing in Mice, in: Developments in Science and Practice of Toxicology, cd.
English: The Collaborative Study Group for the Micronucleus Test, (1992) Micronucleus Test with Mouse Peripheral Blood Erythrocytes by Acridine Orange Supravital Staining: The Summary Report of the 5th Collaborative Study by CSGMT/JEMMS. MMS.
French: The Collaborative Study Group for the Micronucleus Test (1992).
German: The Collaborative Study Group for the Micronucleus Test (1992).
Spanish: The Collaborative Study Group for the Micronucleus Test (1992).
Italian: The Collaborative Study Group for thè Micronucleus Test (1992).
Danish: The Collaborative Study Group for the Micronucleus Test (1992). Micronucleus Test with Mouse Peripheral Blood Erythrocytes by Acridine Orange Supravital Staining: The Summary Report of the 5th Collaborative Study by CSGMT/JEMMS.
Finnish: The Collaborative Study Group for the Micronucleus Test (1992), Micronucleus Test with Mouse Peripheral Blood Erythrocytes by Acridime Orange Supravital Staining: The Summary Report of the 5th Collaborative Study by CSGMT/JEMMS.
Slovak: The Collaborative Study Group for the Micronucleus Test (1992).
Polish: The Collaborative Study Group for the Micronucleus Test (1992).
Hungarian: The Collaborative Study Group for the Micronucleus Test (1992), Micronucleus Test with Mouse Peripheral Blood Erythrocytes by Acridime Orange Supravital Staining: The Summary Report of the 5th Collaborative Study by CSGMT/JEMMS, MMS, Mutation Res., 278. pp.
Slovenian: The Collaborative Study Group for the Micronucleus Test (1992).
Estonian: The Collaborative Study Group for the Micronucleus Test (1992).
English: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS. MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan), (1995) Protocol recommended for the short-term mouse peripheral blood micronucleus test.
French: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995).
German: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995).
Spanish: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995).
Italian: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995).
Danish: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995).
Greek: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995).
Polish: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan)(1995), Protocol recommended for the short-term mouse peripheral blood micronucleus test, Mutagenesis, 10, pp.
Hungarian: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995), Protocol recommended for the short-term mouse peripheral blood micronucleus test, Mutagenesis, 10, pp.
Estonian: The Collaborative Study Group for the Micronucleus Test (CSGMT/JEMMS, MMS: The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan) (1995), Protocol recommended for the short-term mouse peripheral blood micronucleus test, Mutagenesis, 10, pp.
English: Richold, M., Ashby, J., Bootman, J., Chandley, A., Gatehouse, D.G. and Henderson, L., (1990) In Vivo Cytogenetics Assay. In: D.J. Kirkland (Ed.)
German: Richold, M., Ashby, J., Bootman, J., Chandley, A., Gatehouse, D. G. and Henderson, L. (1990), In Vivo Cytogenetics Assay, in: D. J. Kirkland (ed.), Basic Mutagenicity tests.
Danish: Richold, M., Ashby, J., Bootman, J., Chandley, A., Gatehouse, D.G. and Henderson, L. (1990), In Vivo Cytogenetics Assay, in: D.J.
Finnish: Richold, M., Ashby, J., Bootman, J., Chandley, A., Gatehouse, D.G. and Henderson, L. (1990), In Vivo Cytogenetics Assay, in: D.J.
English: Basic Mutagenicity tests. UKEMS Recommended Procedures.
German: UKEMS Recommended Procedures.
Spanish: UKEMS Sub-Committee on Guidelines for Mutagenícity Testing.
Danish: Kirkland (ed.), Basic Mutagenicity tests.
Finnish: Kirkland (ed.), Basic Mutagenicity tests, UKEMS Recommended Procedures.
Greek: In Vivo Cytogenetics Assay, in: D. J. Kirkland (ed.), Basic Mutagenicity tests.
English: UKEMS Sub-Committee on Guidelines for Mutagenicity Testing. Report, Part I, revised.
German: UKEMS Sub-Committee on Guidelines for Mutagenicity Testing.
Spanish: Report, Part 1, revised, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
Danish: UKEMS Recommended Procedures, UKEMS Sub-Committe on Guidelines for Mutagenicity Testing Report, Part 1, revised, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
Greek: UKEMS Recommended Procedures, UKEMS Sub-Committee on Guidelines for Mutagenicity Testing Report, Part I, revised, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
English: Lovell, D.P., Anderson, D., Albanese, R., Amphlett, G.E., Clare, G., Ferguson, R., Richold, M., Papworth, D.G. and Savage, J.R.K., (1989) Statistical Analysis of In Vivo Cytogenetic Assays. In: D.J.
Danish: Lovell, D.P., Anderson, D., Albanese, R., Amphlett, G. E., Clare, G., Ferguson, R., Richold, M., Papworth, D.G. and Savage, J.R.K.
Swedish: Loveli, D. P., Anderson, D., Albanese, R., Amphlett, G. E., Clare, G., Ferguson, R., Richold, M., Papworth, D. G. and Savage, J. R. K. (1989), Statistical Analysis of In Vivo Cytogenetic Assays.
Slovak: Lovell, D. P., Anderson, D., Albanese, R, Amphlett, G E., Clare, G, Ferguson, R, Richold, M., Papworth, D. G. a Savage, J. R. K, (1989) Statistical Analysis of in vivo Cytogenetic Assays, in:D.
Hungarian: Lovell, D. P., Anderson, D., Albanese, R., Amphlett, G. E., Clare, G., Ferguson, R., Richold, M., Papworth, D. G. and Savage J. R. K. (1989), Statistical Analysis of In vivo Cytogenetic Assays, in: UKEMS Subcommittee on Guidelines for Mutagenicity Testing, Report Part III.
English: Kirkland (Ed.) Statistical Evaluation of Mutagenicity Test Data.
French: UKEMS Sub-Committee on Guidelines for Mulagenicity Testing, report.
Italian: Kirkland (ed.), Statistical Evaluation of Mutagenicity Test Data.
Danish: Kirkland (ed.), Statistical Evaluation of Mutagenicity Test Data.
Swedish: In: D. J. Kirkland (cd) Statistical Evaluation oj Mutagenicity Test Dala.
Finnish: UKEMS Subcommittee on Guidelines for Mutagenicity Testing. report.
Greek: Pap-worth, D. G. and Savage, J. R. K. (1989), Statistical Analysis of In Vivo Cytogenetic Assays, in: D. J. Kirkland (ed.), Statistical Evaluation of Mutagenicity Test Data.
Slovak: Kirkland (ed.), Statistical Evaluation of Mutagenecity test Data.
Hungarian: Statistical Evaluation of Mutagenicity Test Data, D. J. Kirkland (ed.)
English: Report, Part III.
Spanish: Report, Part III, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
Danish: Report, Part III, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
Greek: Part III, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
Polish: Report, Part III, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
Estonian: Report, Part III, Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp.
English: For both techniques, after two or three days of incubation, revertant colonies are counted and compared to the number of spontaneous revertant colonies on solvent control plates. Several procedures for performing the bacterial reverse mutation test have been described.
Spanish: En ambos casos, tras dos o tres días de incubación, se cuentan las colonias revertientes y se compara su cantidad con la de colonias revertientes espontáneas en las placas de control con disolvente.
Danish: For begge metoders vedkommende tælles revertantkolonierne efter to-tre dages inkubation, og der sammenlignes med antallet af spontane revertantkolonier på kontrolpladerne med opløsningsmiddel.
Lithuanian: Panaudojant abu metodus ir praėjus 2–3 inkubacijos dienoms, skaičiuojamos revertantų kolonijos ir lyginamos su spontaninių revertantų kolonijomis, auginamomis kontrolinėse lėkštelėse, tirpiklyje, skaičiumi.
English: Either of them is acceptable for conducting experiments both with and without metabolic activation. Some substances may be detected more efficiently using the preincubation method.
Danish: De er begge acceptable til udførelse af forsøgene både med og uden metabolismeaktivering.
Lithuanian: Šios dvi bandymo atlikimo metodikos tinka, atliekant eksperimentus, kai naudojama arba nenaudojama metabolinė aktyvacijos sistema.
English: The following ‘special cases’ could be identified (together with examples of procedures that could be used for their detection): azo-dyes and diazo compounds (3)(5)(6)(13), gases and volatile chemicals (12)(14)(15)(16) and glycosides (17)(18). A deviation from the standard procedure needs to be scientifically justified.
Danish: Følgende »særtilfælde« er konstateret (samt eksempler på fremgangsmåder, der kan benyttes til påvisning): azofarvestoffer og diazoforbindelser (3) (5) (6) (13), gasser og flygtige stoffer (12) (14) (15) (16) og glycosider (17) (18), Afvigelser fra standardmetoden skal begrundes sagligt.
English: Such substances may be detected by E. coli WP2 strains or S. typhimurium TA102 (19), which have an AT base pair at the primary reversion site. Therefore the recommended combination of strains is:
Danish: typhimurium TA 1535, og
English: typhimurium TA1535, and S. typhimurium TA1537 or TA97 or TA97a, and
Danish: typhimurium TA 1537, TA97 eller TA97a, og
English: benzo[a]pyrene
French: Amino-2 anthracène
German: 2-Aminoantracen
Spanish: Benzo[a]pireno
Italian: 2-amminoantracene
Portuguese: 2-aminoantraceno
Danish: benzo[a]pyren
Swedish: 2-aminoantracen
Finnish: 2-aminoantraseeni
Greek: 2-αμινοανθρακένιο
Slovak: benzo[a]pyrén
Polish: 2-aminoantracen
Hungarian: Benzo[a]pirén
Slovenian: benzo[a]piren
Estonian: Benso(a)püreen
Latvian: benzopirēns
Lithuanian: benzpirenas
English: cyclophosphamide monohydrate
French: La substance suivante convient comme témoin positif pour la méthode d'activation métabolique réductrice:
German: Die folgende Substanz eignet sich als Positivkontrolle bei der reduktiven Stoffwechselaktivierungsmethode
Spanish: Monohidrato de ciclofosfamida
Italian: Le seguente sostanza è un controllo positivo adatto per il metodo di attivazione metabolica riduttiva:
Portuguese: A seguinte substância é um controlo positivo apropriado para o método de activação metabólico redutor:
Danish: cyclophosphamidmonohydrat
Swedish: Höljande substans är en lämplig positiv kontroll for den reduktiva metaboliska aktiveringsmetoden:
Greek: Η ακόλουθη ουσία είναι ένας κατάλληλος Οπτικός μάρτυρας για τη μέθοδο αναγωγικής μεταβολικής ενεργοποίησης:
Slovak: cyklofosfamid monohydrát
Hungarian: Ciklofoszfamid monohidrát
Slovenian: ciklofosfamid monohidrat
Estonian: Tsüklofosfamiidmonohüdraat
Latvian: ciklofosfamīda monohidrāts
Lithuanian: ciklofosfamido monohidratas
English: Congo Red
Danish: Congo-rødt
Slovak: Congo Red (červeň Congo)
Hungarian: Kongó vörös
Slovenian: Kongo rdeče
Latvian: Kongo sarkanais
Lithuanian: Kongo raudonasis
English: 2-nitrofluorene
Spanish: 2-Nitrofluoreno
Danish: 2-nitrofluoren
Slovak: 2-nitrofluorén
Hungarian: 2-Nitro-fluorén
Slovenian: 2-nitrofluoren
Latvian: 2- nitrofluorēns
Lithuanian: 2-nitrofluorenas
English: Cumene hydroperoxide
Spanish: Hidroperóxido de cumeno
Danish: cumenbydroperoxid
Slovak: kumén hydroperoxid
Hungarian: Kumén-hidroperoxid
Slovenian: kumol hidroperoksid
Latvian: kumola hidroperoksīds
Lithuanian: kumeno hidroksiperoksidas
English: Furylfuramide (AF2)
Spanish: Furilfuramida (AF2)
Italian: ceppi contenenti plasmidi
Danish: furylfuramid (AF2)
Greek: Στελέχη περιέχονται πλασμίδιο
Slovak: furylfuramid (AF2)
Hungarian: Furil-furamid (AF2)
Slovenian: furilfuramid (AF2)
Latvian: furilfuramīds (AF2)
Lithuanian: Furilfuramidas (AF2)
English: In: Short-term Test Systems for Detecting Carcinogens. Ed.
Spanish: Norpoth K. H. and Garner, R. C Springer, Berlin-Heidelberg-New York, pp.
Danish: Norpoth K.H. and Garner, R.C., Springer, Berlin-Heidelberg-New York, pp.
Greek: Nor-poth K. H. and Garner, R. C., Springer. Bertin-Heidclberg-Ncw York, pp.
Hungarian: Norpoth K. H. and Garner, R. C, Springer, Berlin-Heidelberg-New-York, pp.
English: In: Basic Mutagenicity Tests: UKEMS Part 1 Revised.
Danish: I.R., Wilcox, P., Callender, R.D. and Foster R. (1980), Bacterial Mutation Assays, in: Basic Mutagenicity Tests: UKEMS Part 1 Revised, ed.
Greek: G., Rowland, 1. R., Wilcox, P., Callender, R. D. and Foster R. (1980), Bacterial Mutation Assays, in: Basic Mutageniciry Tests: UKEMS Part 1 Revised, ed.
English: In: Handbook of Mutagenicity Test Procedures. 2nd Edition. Ed.
Spanish: Kilbey, B. J., Legator, M., Nichols, W. and Ramel, C., Elsevier, Amsterdam-New York-Oxford, pp.
Danish: Kilbey, B. J., Legator, M., Nichols, V. and Ramel, C, Elsevier, Amsterdam-New York-Oxford, pp.
Greek: Kilbey, B. J., Legator, M., Nichols, W. and Ramel, C., Elsevier, Amsterdam-New York-Oxford, pp.
Hungarian: Kilbey, B. J., Legator, M., Nichols, W. and Ramel, C, Elsevier, Amsterdam-New York-Oxford, pp.
English: Mol.
Danish: Mutagen.
Hungarian: Mutagen.
English: Tamura, G., Gold, C., Ferro-Luzzi, A. and Ames, B.N., (1980) Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora. Proc.
French: Tamura, G., Gold, C, Ferro-Luzzi, A. and Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
German: Tamura, G., Gold, C, Ferro-Luzzi, A. and Arnes, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Spanish: Tamura, G., Gold, C, Ferro-Luzzi, A. and Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Italian: Tamura, G., Gold, C, Ferro-Luzzi, A. and Ames, B. N. (1980), Fecalase: A Model for Activation of Die- tary Glycosides to Mutagens by Intestinal Flora, Proc. Natl.
Danish: Tamura, G., Gold, C, Ferro-Luzzi, A. and Arnes, B. N. (1980), Fecalase: A Model for Activation of Dictary Glycosides to Mutagens by Intestinal Flora, Proc.
Swedish: Tamura, G., Gold, C, Ferro-Luzzi, A. and Arnes, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Finnish: Tamura, G., Gold, C, Ferro-Luzzi, A. and Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Greek: Tamura, G., Gold, C, Ferro-Luzzi, A. and Ames, Β. Ν. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Slovak: Tamura, G, Gold, C, Ferro-Luzzi, A. a Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Polish: Tamura, G., Gold, C., Ferro-Luzzi, A. and Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc. Natl.
Slovenian: Tamura, G., Gold, C, Ferro-Luzzi, A., in Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
Estonian: Tamura, G., Gold, C, Ferro-Luzzi, A. and Ames, B. N. (1980), Fecalase: A Model for Activation of Dietary Glycosides to Mutagens by Intestinal Flora, Proc.
English: Part II.
Spanish: and Tweats, D. J. (1989), Analysis of Data from Microbial Colony Assays, in: UKEMS Sub-Committee on Guidelines for Mulagenicity Testing, Part II.
Danish: (1989), Analysis of Data from Microbial Colony Assays, in: UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Part II.
English: For toxic substances, the highest concentration tested should not reduce survival below 5 to 10 %.
French: Dans le cas de substances toxiques, la concentration maximale testée ne fera pas descendre le taux de survie en dessous de 5 à 10 %.
German: Bei toxischen Substanzen sollte die höchste Konzentration die Überlebensrate nicht unter 5 bis 10 % senken.
Spanish: En caso de sustancias tóxicas, la concentración máxima probada no reducirá el índice de supervivencias a menos del 5-10 %.
Italian: Occorre far uso di almeno 5 concentrazioni adeguatamente intervallate della sostanza in esame. Per le sostanze tossiche la concentrazione più elevata usata nel test non deve ridurre la sopravvivenza a meno del 5-10 %.
Portuguese: No caso de substâncias tóxicas a concentração máxima testada não deverá diminuir a taxa de sobrevida abaixo de 5 % a 10 %.
Dutch: Voor toxische stoffen mag de hoogste geteste concentratie het overlevingspercentage niet tot minder dan 5 à 10 % verlagen.
Danish: Når der testes toksiske stoffer, bør den højeste koncentration ikke reducere overlevelsesgraden til mindre end 5 til 10 %.
Swedish: För toxiska ämnen ska den högsta koncentrationen som testas inte minska överlevnadsgraden till mindre än 5–10 %.
Finnish: Myrkyllisillä aineilla korkein testattu pitoisuus ei saa aiheuttaa yli 5-10 %.m kuolleisuutta.
Greek: Για τοξικές ουσίες, η υψηλότερη δοκιμαζόμενη συγκέντρωση δεν πρέπει να μειώνει την επιβίωση κάτω από 5 έως 10 %.
Slovak: Pri toxických látkach by nemala najvyššia testovaná koncentrácia znižovať prežívanie pod 5 % až 10 %.
Polish: W odniesieniu do substancji toksycznych, najwyższa wielkość testowego stężenia nie powinna obniżać liczby komórek, które zachowały żywotność poniżej poziomu 5–10 %.
Hungarian: Mérgező anyagoknál a legnagyobb vizsgált koncentráció a túlélési arányt nem csökkentheti 5–10 %-ot meghaladó mértékben.
Slovenian: V primeru strupenih snovi pri najvišji koncentraciji preživetje ne sme pasti pod 5 do 10 %.
Latvian: Toksiskām vielām izvēlas tādu lielāko koncentrāciju, lai izdzīvotu vismaz 5–10 % šūnu.
Lithuanian: Toksinių medžiagų atveju, didžiausia tiriamoji koncentracija neturėtų sumažinti kolonijų išgyvenimo mažiau nei 5–10 %.